Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. (2013)
Attributed to:
Centre for Cognitive Ageing & Cognitive Epidemiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eurpsy.2011.07.005
PubMed Identifier: 21964484
Publication URI: http://europepmc.org/abstract/MED/21964484
Type: Journal Article/Review
Volume: 28
Parent Publication: European psychiatry : the journal of the Association of European Psychiatrists
Issue: 1
ISSN: 0924-9338